The expression of CRH mRNA in AD group were reduced to 0.37-fold, as compared with that of blank control (p<0.05) and the CRH mRNA expression have no changes after BSYQ treatment (Fig. 5 above). The gene discussed is CRH; the disease is Alzheimer disease.